Process and methods
3 Who is involved in producing the QIPP key therapeutics document?
The Medicines and Prescribing Centre is part of NICE's Centre for Clinical Practice (CCP). The Medicines and Prescribing Centre consists of a programme director, associate directors and clinical, technical, project and administrative staff. For the production of the QIPP key therapeutics document, senior members of the medicines evidence or medicines advice teams within the Medicines and Prescribing Centre assist the Department of Health's QIPP Medicines Use and Procurement Wider Reference Group (WRG) in the review of existing, and the identification of new, key therapeutic topics. They are also responsible for:
developing and reviewing processes and methods for producing the QIPP key therapeutics document
prioritising and selecting therapeutic content for the QIPP document once the key therapeutic topics have been selected
preparing the QIPP key therapeutics document for publication, including identifying the best available evidence for each topic
liaising with key groups to help ensure the content is relevant and useful
providing editorial and technical quality assurance of the content of the QIPP key therapeutics document
ensuring timelines and quality assurance standards are followed
reviewing and updating content of the QIPP key therapeutics document where required.
To develop the QIPP key therapeutics document, the Medicines and Prescribing Centre works closely with members of other NICE teams, particularly wider NICE teams involved with QIPP, to avoid overlap with other programmes and potential duplication of effort. These include; Topic Selection, Technology Appraisals, Clinical Guidelines, Communications (including Publishing), Evidence Information Services and Guidance Information Services. Their roles will be defined in the final version of the process guide.
3.3 The Health & Social Care Information Centre (H&SCIC) and NHS Business Service Authority (NHSBSA)
The H&SCIC is responsible for the development of QIPP prescribing comparators, using data provided by the NHSBSA. The NICE Medicines and Prescribing Centre liaises with the H&SCIC and the NHSBSA at regular intervals to ensure that their work on prescribing data and comparators is relevant to the QIPP key therapeutics document.
The Department of Health runs 2 groups to support the QIPP medicines use and procurement work stream. The QIPP WRG oversees this work stream and membership includes representatives of NHS organisations. The QIPP Partners Group includes representatives from medicines and devices trade associations. The QIPP WRG and QIPP Partners Group provide feedback on the scope and content of the QIPP key therapeutics document at various points throughout the process, but NICE approves the process and content for the QIPP key therapeutics document.
NICE staff will be required to comply with the NICE code of conduct on conflicts of interest. For more information about how NICE deals with conflicts of interest, please see A code of practice for declaring and dealing with conflicts of interest.